Abstract
Background: Stage IV breast cancer confers a poor prognosis with median survivals of 18-24 months. Surgical resection of hepatic metastasis is not a consensual treatment given the lack of evidence of benefit. The majority of patients are not fit for surgery because of the physical condition and disseminated disease, so the patients proposed to surgery are limited. The authors pretend to evaluate the long-term outcome of patients with breast cancer liver metastases submitted to hepatic surgery in one single institution.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
